Generalisert angst, oversikt: Diagnosen
Depresjon, panikklidelse og sosial angst (frykt for å bli gransket av andre mennesker) må utelukkes. De karakteristiske symptomene må være tilstede, og man må avklare om det foreligger en vedvarende nervøs legning.
Klargjøring av en del andre livsstilsvaner kan ha betydning både for diagnostikk og behandling - søvn, døgnrytme, alkoholbruk, røyking, inntak av vanedannende medikamenter, familie- og arbeidssituasjon. Tidlig i sykdomsforløpet vil legen utføre en generell kroppsundersøkelse for å utelukke underliggende sykdom. Såfremt ikke sykdomsbildet endrer seg påfallende, er det liten grunn til stadig å gjenta slike undersøkelser ved senere oppblussinger av angsten.
Vil du vite mer
- Ulike angsttilstander, en oversikt
- Generalisert angstlidelse, en oversikt
- Generalisert angstlidelse, forekomst
- Generalisert angstlidelse, symptomer og tegn
- Generalisert angstlidelse, diagnostikk
- Generalisert angstlidelse, behandling
- Generalisert angstlidelse, prognose
- Generalisert angstlidelse, årsaker
- Antidepressiva
- Benzodiazepiner
- Forhøyet stoffskifte
- Depresjon
- Panikklidelse
- Sosial fobi
- Mental Helse Norge
- Angstringen Norge
Dette dokumentet er basert på det profesjonelle dokumentet Generalisert angstlidelse . Referanselisten for dette dokumentet vises nedenfor
- Hoge EA, Ivkovic A, Fricchione GL, Generalized anxiety disorder: diagnosis and treatment. BMJ 2012;345: e7500. www.bmj.com
- McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender Differences in Anxiety Disorders: Prevalence, Course of Illness, Comorbidity and Burden of Illness. J Psychiatr Res 2011; 45: 1027–35. pmid:21439576 PubMed
- Malt U, Andressen OA, Malt EA, Melle I, Årsland D (red). Lærebok i psykiatri. Oslo: Gyldendal akademisk, 2018.
- Pansepp J Affective neuroscience. The foundations of human and animal emotions. New York: Oxford University Press, USA, September 3, 2004; ISBN-13: 978-0195178050
- Nordahl HM, Borkovec TD, Hagen R, et al. Metacognitive therapy versus cognitive-behavioural therapy in adults with generalised anxiety disorder. BJPsych Open 2018; 4: 393-400. pmid:30294448 PubMed
- Fricchione G. Generalized anxiety disorder. N Engl J Med 2004; 351: 675-82. PubMed
- Simon NM, Blacker D, Korbly NB, et al. Hypothyroidism and hyperthyroidism in anxiety disorders revisited: new data and literature review. J Affect Disord 2002; 69: 209-17. PubMed
- Aarre TF. En mindre medisinsk psykiatri. Oslo: Universitetsforlaget, 2018. tidsskriftet.no
- Nordmo E, Vorren S. Lyrica - norske bivirkningsmeldinger om misbruk. RELIS 2014.
- Roszkowska J, Geraci SA. Management of insomnia in the geriatric patient. Am J Med. 2010 Dec;123(12):1087-90. PubMed
- Stein MB, Sareen J. Clinical Practice. Generalized Anxiety Disorder. N Engl J M. 2015; 373:2059-2068. pmid:26580998 PubMed
- Covin R, Ouimet AJ, Seeds PM, et al. A meta-analysis of CBT for pathological worry among clients with GAD. J Anxiety Disord. 2008;22:108-116. PubMed
- Hendriks GJ, Oude Voshaar RC, Keijsers GP, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2008;117:403-411. PubMed
- Kriz S, Solberg B. Kognitiv atferdsterapi. Norsk barne- og ungdomspsykiatrisk forening, veileder i BUP. Publisert 07. juli 2017. legeforeningen.no
- Olthuis JV, Watt MC, Bailey K, et al. Therapist-supported internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016;(3):CD011565. Cochrane (DOI)
- Gosselin P, Ladouceur R, Morin CM, Dugas MJ, Baillargeon L. Benzodiazepine Discontinuation Among Adults With GAD: A Randomized Trial of Cognitive-Behavioral Therapy. J Consult Clin Psychol 2006; 74: 908-19. PubMed
- Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ 2011; 342: d1199. BMJ (DOI)
- Slee A, Nazareth I, Bondaronek P et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet 2019; S0140-6736: 31793-8. pmid:30712879 PubMed
- Lenze EJ, Rollman BL, Shear K, et al. Escitalopram for older adults with generalized anxiety disorder. JAMA 2009; 301: 295-303. Journal of the American Medical Association
- Frampton J. Pregabalin: A review of its use in adults with generalized anxiety disorder. CNS Drugs 2014; 9: 835-54. pmid:25149863 PubMed
- Starcevic V. Anxiety states: a review of conceptual and treatment issues. Curr Opin Psychiatry 2006; 19: 79-83. PubMed
- Creswell C, Waite P, Cooper PJ, Assessment and management of anxiety disorders in children and adolescents. Arch Dis Child 2014;99: 674-678 PubMed
- Herring MP, O'Connor PJ, Dishman RK. The effect of exercise training on anxiety symptoms among patients: a systematic review. Arch Intern Med. 2010;170:321-331. PubMed
- Larun L, Nordheim LV, Ekeland E, Hagen KB, Heian F. Exercise in prevention and treatment of anxiety and depression among children and young people. Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD004691. DOI: 10.1002/14651858.CD004691.pub2. DOI
- Stonerock GL, Hoffman BM, Smith PJ, et al. Exercise as Treatment for Anxiety: Systematic Review and Analysis. Ann Behav Med. 2015;49(4):542-56. PubMed
- Jorm AF, Christensen H, Griffiths KM, Parslow RA, Rodgers B, Blewitt KA. Effectiveness of complementary and self-help treatments for anxiety disorders. Med J Aust 2004; 181: S29-46. PMID: 15462640 PubMed
- Parslow R, Morgan AJ, Allen NB. Effectiveness of complementary and self-help treatments for anxiety in children and adolescents. Med J Aust 2008; 188: 355-9. pmid:18341460 PubMed
- Ravindran AV, da Silva TL. Complementary and alternative therapies as add-on to pharmacotherapy for mood and anxiety disorders: a systematic review. J Affect Disord 2013; 150: 707-19. pmid:23769610 PubMed
- Krisanaprakornkit T, Krisanaprakornkit W, Piyavhatkul N, Laopaiboon M. Meditation therapy for anxiety disorders. Cochrane Database Syst Rev. 2006; 1: CD004998. pmid:16437509 PubMed
- Robinson J, Biley FC, Dolk H. Therapeutic touch for anxiety disorders. Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006240. DOI: 10.1002/14651858.CD006240.pub2. DOI
- Miyasaka LS, Atallah ÁN, Soares B. Passiflora for anxiety disorder. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD004518. DOI: 10.1002/14651858.CD004518.pub2. DOI
- Bruce SE, et al. Influence of psychiatric comorbidity on recovery and recurrence in generela anxiety disorder, social phobia, and panic disorder: a 12-year prospective study. Am J Psychiatry 2005; 162: 1179-87. American Journal of Psychiatry
- DeMartini J, Patel G, Fancher TL. Generalized Anxiety Disorder. Ann Intern Med. 2019 Apr 2;170(7):ITC49-ITC64. PMID: 30934083. PubMed
- Feltner DE, Crockatt JG, Dubovsky SJ et al. A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder. J Clin Psychopharmacol 2003; 23: 240-9. PubMed
- Baldwin DS, Polkinghorn C. Evidence-based pharmacotherapy of Generalized Anxiety Disorder. Int J Neuropsychopharmacol 2005; 8: 293-302. PubMed
- Herr NR, Williams JW Jr, Benjamin S, et al. Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. JAMA. 2014 ;312(1):78-84. doi: 10.1001/jama.2014.5950 DOI